Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Application Of Biodentine Rd94 Dentin Substitute

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07314580Recruiting

Clinical and Radiological Evaluation of Dental Autotransplantation in the Anterior Region in Young Patients

NCT01737229Not ApplicableCompletedPrimary

Efficacy and the Safety Study of RD94 in Patients With Endodontic Care

Showing all 2 trials

Research Network

Common Treatments

  • Application Of Biodentine Rd94 Dentin Substitute1
  • Premolar Autotransplantation1

Active Sponsors

  • AscoPharm is conducting the study under the responsibility of SEPTODONT1
  • University of Barcelona1
  • Ascopharm Groupe Novasco1

Top Investigators

Related Conditions

  • Tooth Loss1

Activity Timeline